NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

DNA定序的全球市場:研究、用途、臨床市場

Global DNA Sequencing: Research, Applied and Clinical Markets

出版商 BCC Research 商品編碼 845209
出版日期 內容資訊 英文 351 Pages
訂單完成後即時交付
價格
DNA定序的全球市場:研究、用途、臨床市場 Global DNA Sequencing: Research, Applied and Clinical Markets
出版日期: 2019年05月16日內容資訊: 英文 351 Pages
簡介

全球定序市場,預計從2018年的107億美元到2023年擴大到244億美元,其間預計為18.0%的年複合成長率。

本報告提供全球DNA定序市場調查,市場概要,技術,市場趨勢的分析與預測,研究/臨床用途為基礎的分析,競爭情形,專利趨勢,及主要企業的簡介等系統性資訊。

第1章 簡介

第2章 摘要、亮點

第3章 概要

  • 簡介
  • 定序市場
  • 定序促進成長的要素
  • 定序的應用
  • 定序產業

第4章 技術背景

  • DNA的重要性
  • 遺傳的變異、分析
  • 定序的歷史
  • 定序技術
  • Sanger法定序
  • 次世代定序
  • 資訊學技術
  • 臨床定序的引進的課題

第5章 定序的舉措

第6章 研究、用途

  • 簡介
  • 研究開發用途
  • 用途
    • DTC
    • 生物藥物
    • 農業
    • 法醫學
    • 微生物
    • 合成生物學

第7章 臨床用途

  • 簡介
  • 癌症
  • 孟德爾型遺傳病
  • 生殖健康
  • 微生物學、感染疾病
  • 複合疾病
  • 移植診斷

第8章 定序產業

  • 定序設備
  • 長領導定序
  • 靶向序列捕獲、放大
  • 遺傳基因編輯
  • 定序資訊學
  • 定序資料庫區塊鏈
  • 液態切片化驗
  • 生殖健康診斷
  • 非侵入性產前檢查
  • 胎兒細胞 NIPT
  • 農業
  • 消費者基因學
  • DNA資料儲存

第9章 收購、策略聯盟

  • 收購
  • 策略聯盟
  • 主要趨勢

第10章 定序市場

  • 成長促進因素
  • 定序市場
  • 臨床診斷定序市場
  • 癌症臨床診斷定序市場
  • 生殖健康市場
  • 移植市場
  • 地區市場

第11章 專利檢討/新開發

  • 循環腫瘤細胞
  • 胞外體
  • 無細胞DNA
  • 定序相關的專利糾紛

第12章 企業簡介

目錄
Product Code: BIO045G

Report Highlights:

The global sequencing market should grow from $10.7 billion in 2018 to $24.4 billion by 2023, with a compound annual growth rate (CAGR) of 18.0% for the period of 2018-2023.

Sequencing services market should grow from $5.5 billion in 2018 to $14.0 billion by 2023, with a CAGR of 20.4% for the period of 2018-2023.

Sequencing workflow products market should grow from $5.2 billion in 2018 to $10.5 billion by 2023, with a CAGR of 15.1% for the period of 2018-2023.

Report Scope:

The scope of the report includes sequencing technologies, applications, industries, initiatives, patents and companies. The markets for sequencing products and services are given for the years 2017, 2018, and 2023.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the significant research initiatives that impact sequencing applications. Of particular interest is a discussion of population-scale sequencing projects throughout the world, and their likely impact on the sequencing industry. The main market driving forces for sequencing products and services are listed and discussed.

The report quantifies the sequencing markets by delivered format, including sequencing workflow products (sample preparation kits and reagents, sequencing instruments and consumables, and informatics) and sequencing services (clinical diagnostics and sequencing services to applied market customers).

The sample preparation kits and reagents market is quantified by type, that is, DNA isolation and extraction; target enrichment; and library preparation. The sequencing instruments and consumables market given by platform (Sanger, NGS and 3GS) and by product type (instruments, consumables).

The sequencing services market is analyzed by end user application (applied, clinical, research and development) and by genome type (human, non-human). Within sequencing services, the applied market is analyzed by end user application (agriculture, biopharma, consumer, microbiology, population-scale genomics, synthetic biology, and other).

Also within sequencing services, the clinical market is analyzed and quantified on a number of levels, including by disease category (cardiovascular, clinical microbiology and infectious diseases, Mendelian disorders, metabolic/immune disorders, neurology, oncology, reproductive health, and transplant medicine); by sequenced region (single gene, targeted region/multi-gene, exome, whole genome, and metagenome); by assay type (screening/early detection, diagnosis, therapy guidance, monitoring).

Within the diagnostics market, the oncology, reproductive health and transplant medicine market segments are analyzed as follows. The oncology market segment is analyzed by assay type; by sequenced region; and by indication (bladder, brain, breast, colorectal, cancer unknown primary, gastrointestinal stromal tumor, kidney, leukemia/lymphoma, lung, melanoma, pan-cancer, prostate, thyroid, and other cancer). The reproductive health market segment is analyzed by assay type; sequenced region; and application (carrier screening, in-vitro fertilization, newborn screening and non-invasive prenatal screening). The transplant market segment is analyzed by assay type; sequenced region; and organ type (lung, heart, liver, and kidney).

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific, and the rest of the world.

Industry sectors analyzed include Sequencing instruments; long-read sequencing; target enrichment; gene editing; informatics; blockchain; liquid biopsy; reproductive health diagnostics; consumer genomics; agriculture; and DNA data storage.

More than 200 companies in the sequencing industry are profiled in this report.

BCC Research provides a summary of the more than 200 of the main industry acquisitions and strategic alliances from January 2017 through March 2019, including key alliance trends.

Report Includes:

  • 27 data tables and 79 additional tables
  • An overview of global market for DNA sequencing and discussion of applications in research, applied and clinical markets
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Description of sequencing markets by workflow, including sample preparation products; sequencing instruments and consumables; informatics; and sequencing services
  • Coverage of Sanger and next-generation technologies in detail
  • Detailed description of key sequencing research & development programs such as American Gut Consortium, BabySeq and Blood Profiling Atlas
  • A look at the current trends and recent developments in the market
  • Company profiles of the major players of the market, including 23Andme Inc., Mayo Medical Laboratories, Novogene Co. Ltd., Qiagen NV, Roche Holding AG, Thermo Fisher Scientific Inc. and Zhejiang Dian Diagnostics Co. Ltd.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview

  • Introduction
  • Sequencing Markets
  • Sequencing Growth Driving Forces
  • Sequencing Applications
  • Sequencing Industry

Chapter 4: Technology Background

  • Importance of DNA
  • Genetic Variation and Analysis
  • History of Sequencing
  • Sequencing Technologies
  • Sanger Sequencing
  • Next Generation Sequencing
  • Informatics Technologies
    • Base Calling
    • Mapping to a Reference Sequence
    • Variant Analysis
  • Clinical Sequencing Adoption Challenges

Chapter 5: Sequencing Initiatives

  • Sequencing Initiatives
  • American Gut Consortium
  • BabySeq
  • Blood Profiling Atlas
  • Cancer-ID
  • Cancer Moon Shots Program
  • China Precision Medicine Initiative
  • ClinGen
  • Epifemcare
  • France Genomic Medicine Plan
  • Friends of Cancer Research Project
  • Human Cell Atlas Consortium
  • Immunomonitor Consortium
  • Integration of Imaging and Fluid-based Tumor Monitoring in Cancer Therapy Program
  • Liquid Biopsies and Imaging for Improved Cancer Care
  • Lung-Map
  • Matchmaker Exchange
  • Metagenomics and Metadesign of Subways and Urban Biomes (MetaSub)
  • Million Veteran Program
  • Mind
  • MedSeq
  • National Microbiome Initiative
  • Next Generation Single Cell Analysis Program
  • Precancer Atlas
  • Precision Medicine Initiative
  • Prompt
  • QuIP Project
  • TopMed
  • Population Sequencing Programs

Chapter 6: Research and Applied Applications

  • Introduction
  • Research and Development Applications
  • Applied Applications
    • Direct to Consumer
    • Biopharma
    • Agriculture
    • Forensics
    • Microbiome
    • Synthetic Biology

Chapter 7: Clinical Applications

  • Introduction
  • Cancer Applications
  • Mendelian Disorders Applications
  • Reproductive Health Applications
  • Microbiology and Infectious Disease Applications
  • Complex Disorders Applications
  • Transplant Diagnostics Applications

Chapter 8: Sequencing Industry

  • Introduction
  • Sequencing Instruments Industry
  • Long Read Sequencing Industry
  • Target Enrichment and Amplification Industry
  • Gene Editing Industry
  • Sequencing Informatics Industry
  • Sequencing Data-Based Blockchain Industry
  • Liquid Biopsy Assay Industry
  • Reproductive Health Diagnostics Industry
  • Non-invasive Prenatal Testing Industry
  • Fetal Cell NIPT Industry
  • Agriculture Industry
  • Consumer Genomics Industry
  • DNA Data Storage Industry

Chapter 9: Acquisitions and Strategic Alliances

  • Acquisitions
  • Strategic Alliances
  • Key Trends
    • 2017 Alliances
    • 2018 Alliances
    • 2019 Alliances

Chapter 10: Sequencing Markets

  • Growth Driving Forces
  • Sequencing Market
    • Sequencing Instruments and Consumables Market
    • Sample Prep Kits and Reagents Market
    • Informatics Market
    • Sequencing Services Market
    • Agriculture Market
    • Biopharma Market
    • Consumer Genomics Market
    • Microbiology Market
    • Population Genomics Market
    • Synthetic Biology Market
  • Clinical Diagnostic Sequencing Market
    • Cardiology Market
    • Clinical Microbiology and Infectious Disease Market
    • Mendelian Disorders Market
    • Metabolic/Immune Disorders Market
    • Neurology Market
    • Oncology Market
    • Reproductive Health Market
    • Transplant Market
    • Single Gene Market
    • Multigene/Hotspot Market
    • Exome Sequencing Market
    • Whole Genome Sequencing Market
    • Screening/Early Detection Market
    • Diagnosis Market
    • Therapy Guidance Market
    • Monitoring Market
  • Cancer Clinical Diagnostics Sequencing Market
    • Lung Cancer Market
    • Breast Cancer Market
    • Colorectal Cancer Market
    • Pan-Cancer Market
    • Other Cancers
    • Oncology Screening/Early Detection Market
    • Oncology Diagnosis Market
    • Oncology Therapy Guidance Market
    • Oncology Monitoring Market
    • Role of Novel Biomarkers for Oncology Therapy Guidance and Monitoring
  • Reproductive Health Markets
    • IVF Market
    • Newborn Screening Market
    • Carrier Screening Market
    • NIPT Market
  • Transplant Market
  • Geographical Market

Chapter 11: Patent Review/ New Developments

  • Circulating Tumor Cell Patents
  • Exosome Patents
  • Cell-free DNA Patents
  • Sequencing-Related Patent Disputes

Chapter 12: Company Profiles

  • 3BILLION INC.
  • 10X GENOMICS, INC.
  • 23ANDME INC.
  • ADAPTIVE BIOTECHNOLOGIES INC.
  • ADMERA HEALTH
  • AGILENT TECHNOLOGIES INC.
  • ALCEDIAG
  • ALMAC GROUP LTD.
  • AMARANTUS BIOSCIENCE HOLDINGS INC.
  • AMBRY GENETICS
  • APERIOMICS INC.
  • ARCHER DX
  • ARUP LABORATORIES
  • ASTRIDBIO TECHNOLOGIES KFT.
  • ASURAGEN INC.
  • ATHENA DIAGNOSTICS INC.
  • ATRECA INC.
  • BASE4 INNOVATION LTD.
  • BAYLOR GENETICS
  • BECTON, DICKINSON AND CO.
  • BELLWETHER BIO INC.
  • BERRY GENOMICS CO. LTD.
  • BGI SHENZHEN
  • BIOARRAY S.L.
  • BIOCEPT INC.
  • BIODESIX INC.
  • BIOMARX INC.
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE LTD.
  • BLUEPRINT GENETICS
  • BLUESTAR GENOMICS INC.
  • BOREAL GENOMICS
  • CAMBRIDGE EPIGENETIX LTD.
  • CANCER GENETICS
  • CAREDX INC.
  • CARIS LIFE SCIENCES
  • CEGAT GMBH
  • CELLMAX LIFE
  • CELSEE DIAGNOSTICS
  • CENTOGENE AG
  • CERGENTIS BV
  • CHRONIX BIOMEDICAL
  • CIRCULOGENE THERANOSTICS
  • CIRCULOMICS INC.
  • COFACTOR GENOMICS INC.
  • COLOR GENOMICS
  • COOPER SURGICAL INC.
  • CORIELL LIFE SCIENCES INC.
  • COSMOSID
  • CS GENETICS LTD.
  • CYGNUS BIOSCIENCES CO. LTD.
  • CYNVENIO BIOSYSTEMS INC.
  • DANAHER CORP.
  • DATAR CANCER GENETICS LTD.
  • DARUI BIOTECHNOLOGY CO. LTD.
  • DEPIXUS
  • DEVYSER AB
  • DIACARTA INC.
  • DIAGNOMICS
  • DIPLOID
  • DIRECTED GENOMICS LLC
  • DIRECT GENOMICS CO. LTD.
  • DNA ELECTRONICS LTD.
  • DNANEXUS INC.
  • DOVETAIL GENOMICS LLC
  • ELECTRONIC BIOSCIENCES
  • ENVISION GENOMICS
  • EPIC SCIENCES INC.
  • ESPERITE NV
  • EUROFINS SCIENTIFIC
  • EXACT SCIENCES CORP.
  • EXPEDEON AG
  • EZLIFE BIO INC.
  • FABRIC GENOMICS
  • FLUXION BIOSCIENCES INC.
  • FREENOME INC.
  • FRY LABORATORIES LLC
  • FULL GENOMES CORPORATION
  • FUSION GENOMICS CORP.
  • GENAPSYS INC.
  • GENCOVE, INC.
  • GENDX BV
  • GENE BY GENE LTD.
  • GENEDX INC.
  • GENETICS RESEARCH LLC
  • GENOMATIX SOFTWARE GMBH
  • GENOME.ONE PTY LTD
  • GENOMIC EXPRESSION
  • GENOMIC HEALTH INC.
  • GENOME PROFILING LLC
  • GENOMNIA SRL
  • GENOMONCOLOGY
  • GENOSPACE
  • GENOOX
  • GENXOSOME TECHNOLOGIES INC.
  • GIGAGEN INC.
  • GOLDEN HELIX
  • GRAIL INC.
  • GRANDOMICS BIOSCIENCES CO. LTD.
  • GUARDANT HEALTH INC.
  • GUARDIOME
  • HELITEC
  • HELIX OPCO LLC
  • HISTOGENETICS LLC
  • HTG MOLECULAR DIAGNOSTICS INC.
  • HUMAN LONGEVITY INC.
  • ILLUMINA INC.
  • INEX INNOVATIONS EXCHANGE PTE. LTD.
  • INIVATA LTD.
  • INTERPACE DIAGNOSTICS LLC.
  • INVITAE
  • INVIVOSCRIBE INC.
  • IREPERTOIRE INC.
  • KAILOS GENETICS
  • KARIUS INC.
  • KELLBENX INC.
  • KEW INC.
  • KINGMED DIAGNOSTICS CENTER CO. LTD.
  • LABORATORY CORP. OF AMERICA INC.
  • LABORATORY FOR MOLECULAR MEDICINE
  • LEUCINE RICH BIO PVT. LTD.
  • LEXENT BIO INC.
  • LOOP GENOMICS
  • MACROGEN INC.
  • MAPMYGENOME
  • MAYO MEDICAL LABORATORIES
  • MDXHEALTH
  • MEDGENOME LABS PVT. LTD.
  • MENARINI SILICON BIOSYSTEMS SPA
  • MERCK KGAA
  • MOGENE LLC
  • MOLECULAR HEALTH GMBH
  • MOLECULARMD CORP.
  • MOLECULAR LOOP BIOSOLUTIONS LLC
  • MYRIAD GENETICS INC.
  • NANOSTRING TECHNOLOGIES INC.
  • NATERA INC.
  • NAVERIS INC.
  • NEOGENOMICS LABORATORIES
  • NEW ENGLAND BIOLABS
  • NEWGENE LTD.
  • NEW ONCOLOGY GMBH
  • NGENEBIO CO. LTD.
  • NIPD GENETICS
  • N-OF-ONE INC.
  • NOVOGENE CO. LTD.
  • NUGEN TECHNOLOGIES INC.
  • NUMEDII
  • NUPROBE INC.
  • NX PRENATAL INC.
  • OMNISEQ CORP.
  • ONCOCYTE CORP.
  • ONCODNA S.A.
  • ONEOME LLC
  • OTHRAM INC.
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC.
  • PAIRNOMIX INC.
  • PANGAEA ONCOLOGY
  • PARADIGM DIAGNOSTICS INC.
  • PARSEQ LAB CO. LTD.
  • PATHWAY GENOMICS CORP.
  • PERKINELMER INC.
  • PERSONAL GENOME DIAGNOSTICS INC.
  • PERSONALIS INC.
  • PIERIANDX
  • POPULATION GENETICS TECHNOLOGIES LTD.
  • PORTABLE GENOMICS LLC
  • POSITIVE BIOSCIENCE
  • PRECIPIO INC.
  • PREDICINE INC.
  • PRENETICS
  • PREVENTIONGENETICS INC.
  • QIAGEN NV
  • QUANTAPORE INC.
  • QUANTUM BIOSYSTEMS INC.
  • QUANTUMDX
  • QUEST DIAGNOSTICS INC.
  • RARECYTE INC.
  • REAL TIME GENOMICS INC.
  • RESOLUTION BIOSCIENCE INC.
  • ROCHE HOLDING AG
  • SCREENCELL
  • SEEKIN
  • SEQUENCING.COM
  • SEVEN BRIDGES GENOMICS INC.
  • SINGLERA GENOMICS INC.
  • SISTEMAS GENOMICOS SL
  • SOFTGENETICS LLC
  • SOPHIA GENETICS
  • SPERA MEDICAL
  • STRAND LIFE SCIENCES PVT. LTD.
  • STRATOS GENOMICS INC.
  • SUPRATECH MICROPATH LABORATORY & RESEARCH INSTITUTE PVT. LTD.
  • SYAPSE
  • TAKARA BIO INC.
  • TEMPUS
  • THERMO FISHER SCIENTIFIC INC.
  • TRACE GENOMICS INC.
  • TROVAGENE INC.
  • TWINSTRAND BIOSCIENCES
  • TWO PORE GUYS INC.
  • UBIQUITY GENOMICS INC.
  • VELA DIAGNOSTICS
  • VERITAS GENETICS
  • VORTEX BIOSCIENCES
  • XING TECHNOLOGIES LLC
  • YIKON GENOMICS CO. LTD.
  • YOURGENE HEALTH PLC
  • ZHEJIANG DIAN DIAGNOSTICS CO. LTD.

List of Tables

  • Summary Table: Global Sequencing Market, by Delivered Format, Through 2023
    • Table 1: Report Scope
    • Table 2: Global Sequencing Market, by Product Type, Through 2023
    • Table 3: Sequencing Market Growth Driving Forces
    • Table 4: Sequencing End Users and Applications
    • Table 5: Key Sequencing Industry Participants by Sector
    • Table 6: DNA Chemical Building Blocks
    • Table 7: DNA Translation and Transcription
    • Table 8: Long-range DNA Structure
    • Table 9: Genetic Variant Types
    • Table 10: Molecular Diagnostic Technology Platforms
    • Table 11: DNA Sequencing Historical Timeline
    • Table 12: Sequencing Technology Development, 1990-2020
    • Table 13: Cost to Sequence a Single Human Genome, 2001-2019
    • Table 14: Sequencing Technology Summary
    • Table 15: Sanger Sequencing Summary
    • Table 16: Sanger Sequencing Improvements
    • Table 17: Advanced Sequencing Technologies
    • Table 18: Roche Next Generation Sequencing Workflow
    • Table 19: Illumina Next Generation Sequencing Workflow
    • Table 20: Thermo Fisher Next Generation Sequencing Workflow
    • Table 21: Next Generation Sequencing Bioinformatics Workflow
    • Table 22: Sequence Annotation Steps
    • Table 23: Challenges for Implementing Clinical Next Generation Sequencing
    • Table 24: Key Sequencing Research and Development Programs
    • Table 25: Population Sequencing Projects, 2016-2019
    • Table 26: Number of Sequencing Projects in GOLD Database, 2014-2018
    • Table 27: Sequencing Projects in GOLD Database, by Sequencing Strategy, 2018
    • Table 28: Main Sequencing Applications
    • Table 29: Genetic Analysis Platform Comparison
    • Table 30: Sequencing Impact on Agricultural Product Classes
    • Table 31: Key Applications in Forensics/Human Identity Sequencing
    • Table 32: Key Applications in Microbial Sequencing
    • Table 33: Genetic Testing Scope
    • Table 34: Key Applications for Sequencing-based Diagnostics
    • Table 35: Cancer Applications
    • Table 36: Mendelian Disorders Applications
    • Table 37: Reproductive Health Screening Applications
    • Table 38: Ethical Issues Associated with Prenatal and Newborn Screening
    • Table 39: Microbiology and Infectious Disease Applications
    • Table 40: Complex Disorder Applications
    • Table 41: Transplant Diagnostics Applications
    • Table 42: Subsectors within the Sequencing Industries
    • Table 43: Advanced Sequencing Industry Company Positioning
    • Table 44: End-to-End Sequencing Approaches
    • Table 45: Long-Read Sequencing Industry
    • Table 46: Target Enrichment Industry
    • Table 47: Gene Editing Tools Industry
    • Table 48: Agricultural Gene Editing Industry
    • Table 49: Sequencing Informatics Industry
    • Table 50: Sequencing Data-Based Blockchain Industry
    • Table 51: Liquid Biopsy Assay Industry: Company Focus
    • Table 52: Example of NGS-based Liquid Biopsy Market Differentiation
    • Table 53: NIPT Industry
    • Table 54: Estimated Number of NIPT Tests, by Company, 2018
    • Table 55: Germany NGS-based Non-invasive Prenatal Diagnostic Companies, 2017
    • Table 56: NIPT Test Licensing, by Country
    • Table 57: Fetal Cell NIPT Industry
    • Table 58: Key Players in Synthetic Biology Agriculture Industry
    • Table 59: Key Players in Consumer Genomics Industry
    • Table 60: DNA Data Storage Industry Key Participants
    • Table 61: Sequencing Industry Acquisitions, January 2017-March 2019
    • Table 62: Sequencing Industry Strategic Alliances, January 2017- March 2019
    • Table 63: Sequencing Market Growth Driving Forces
    • Table 64: Global Sequencing Market, by Format, Through 2023
    • Table 65: Global Instruments and Consumables Market, by Product Type, Through 2023
    • Table 66: Global Sequencing Instruments and Consumables Market, by Product Generation, Through 2023
    • Table 67: Global Sample Preparation Market, by Product Type, Through 2023
    • Table 68: Global Sequencing Services Market, by End User, Through 2023
    • Table 69: Global Sequencing Services Market, by Genome Type, Through 2023
    • Table 70: Global Applied Sequencing Services Market, by Application, Through 2023
    • Table 71: Synthetic Biology Growth Driving Forces
    • Table 72: Global Clinical Diagnostics Sequencing Market, by Disease Category, Through 2023
    • Table 73: Examples of Dilated Cardiomyopathy Test Providers
    • Table 74: Microbial Sequencing Landscape
    • Table 75: Multiple Sclerosis Diagnostic Technologies
    • Table 76: Global Clinical Diagnostics Sequencing Market, by Sequenced Region, Through 2023
    • Table 77: Global Clinical Diagnostics Sequencing Market, by Test Purpose, Through 2023
    • Table 78: NGS-based Preventive Genetic Screening Tests
    • Table 79: Global Cancer Clinical Diagnostics Sequencing Market, by Indication, Through 2023
    • Table 80: National Institute of Health Liquid Biopsy Early Detection Initative
    • Table 81: Five-Year Survival Rate for Ovarian Cancer
    • Table 82: Molecular Thyroid Nodule Classifier Test Company Positioning
    • Table 83: Global Clinical Diagnostics Oncology Sequencing Market, by Test Purpose, Through 2023
    • Table 84: MRI and Liquid Biopsy Methods
    • Table 85: Early Detection Tissue of Origin Approaches
    • Table 86: TMB Diagnostics Landscape
    • Table 87: Global Clinical Diagnostics Sequencing Cancer Market, by Test Complexity, Through 2023
    • Table 88: Global Clinical Reproductive Health Market, by Test Application, Through 2023
    • Table 89: Global Sequencing-based NIPT Market, by Risk Type, Through 2023
    • Table 90: Global Reproductive Health Clinical Sequencing Market, by Sequenced Region, Through 2023
    • Table 91: Global Reproductive Health Clinical Sequencing Market, by Analysis Type, o
    • Table 92: Global Transplant Clinical Sequencing Market, by Analysis Purpose, Through 2023
    • Table 93: Global Transplant Clinical Sequencing Market, by Sequenced Region, Through 2023
    • Table 94: Global Transplant Clinical Sequencing Market, by Organ Type, Through 2023
    • Table 95: Transplant Procedures Performed in the United States, 2016-2018
    • Table 96: Global Sequencing Market, by Region, Through 2023
    • Table 97: Global Sequencing Workflow Products Market, by Region, Through 2023
    • Table 98: Global Sequencing Services Market, by Region, Through 2023
    • Table 99: Global Clinical Diagnostics Sequencing Market, by Region, Through 2023
    • Table 100: CTC-related Patents, by Region, 2008-2018
    • Table 101: Exosome-related Patents, by Region, 2008-2018
    • Table 102: cfDNA-related Patents, by Region, 2008-2018
    • Table 103: Status of Liquid Biopsy and Sequencing-related Patent Disputes
    • Table 104: Data Generated by Platforms
    • Table 105: Sensitivity to Detect Drug Resistant Mutations in Viruses

List of Figures

  • Summary Figure: Global Sequencing Market, by Delivered Format, 2017-2023